Zacks Investment Research
05 Aug 2026, 12:46 UTC · 1h ago
Zimmer Biomet (ZBH) Q2 Earnings and Revenues Beat Estimates
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
05 Aug 2026, 12:46 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Zimmer Biomet reported quarterly earnings of $2.07 per share, beating the Zacks Consensus Estimate of $2.01. — An earnings beat typically supports a positive short-term price reaction for the specific ticker.
+0.30Zimmer Biomet posted quarterly revenues of $2.18 billion, exceeding the Zacks Consensus Estimate by 2.25%. — Revenue growth and beats indicate healthy top-line demand, supporting a bullish outlook for the company.
+0.20Zimmer Biomet shares have gained approximately 6.6% year-to-date, underperforming the S&P 500's 13% gain. — Relative underperformance suggests a lack of strong institutional momentum compared to the broader market.
-0.10Which stocks this story touches
Continue reading
6 related stories
Top 2 movers · tap to explore
The company beat both quarterly earnings and revenue estimates.
Mentioned only in a list of most-viewed stocks with no qualitative data.
Mentioned only in a list of most-viewed stocks with no qualitative data.
Mentioned only in a list of most-viewed stocks with no qualitative data.
Mentioned only in a list of most-viewed stocks with no qualitative data.
Mentioned only in a list of most-viewed stocks with no qualitative data.
Mentioned only in a list of most-viewed stocks with no qualitative data.
Mentioned only in a list of most-viewed stocks with no qualitative data.
Mentioned only in a list of most-viewed stocks with no qualitative data.
Mentioned only in a list of most-viewed stocks with no qualitative data.
Mentioned only in a list of most-viewed stocks with no qualitative data.
Mentioned only in a list of most-viewed stocks with no qualitative data.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
